Why MCC Alone Isn’t Enough for Modern Tablet Pressing
Microcrystalline cellulose (MCC) has been a foundational excipient in tablet formulations for decades. While effective as a filler and compressibility aid, MCC alone often falls short in modern tablet manufacturing environments.
The Limitations of MCC
Manufacturers relying solely on MCC often encounter:
Inconsistent flow in complex blends
Insufficient binding for certain APIs
Increased reliance on additional excipients
Greater formulation complexity
As production speeds increase and formulations diversify, MCC typically requires supplementation to perform reliably.
Why Modern Formulations Need More
Today’s manufacturers demand:
Faster production speeds
Small-batch flexibility
Improved consistency
Cleaner, simplified formulations
Using MCC alone frequently results in:
Added binders and glidants
Increased development time
Greater risk of compression problems
How EviPress™ Improves on Traditional MCC-Based Formulations
EviPress™ is an engineered all-in-one binder system designed to complement or replace traditional MCC-heavy formulations by offering:
Improved flowability
Enhanced binding strength
Reduced sticking and picking
Simplified excipient systems
By consolidating multiple functions into one binder system, EviPress reduces formulation complexity while improving performance.
Conclusion
MCC remains a valuable excipient—but EviPress™ is designed for modern tablet pressing realities, where efficiency, consistency, and flexibility matter.
